Video: Question: Thoughts on therapeutic approaches.
In this portion of the forum, the panel was asked about how they might approach designing therapeutic interventions given the multifaceted nature of both the pathogenic events (and molecules) which lead to AD as well as the complexity of the brain and neural networks.